Sign up
Tech Capital

Respiri enters partnership to develop next generation breath sensors

Respiri’s flagship product connects with a smartphone to detect and measure wheeze.
a smartphone
Respiri's products have been cleared by the U.S. FDA

Respiri Ltd (ASX:RSH) has entered into a partnership with Grey Innovation to develop the next generation of its “AirSonea” breath sensor with a new creative design and superior ergonomics.

The company’s shares closed 17% higher on Tuesday, at $0.034.

Respiri is a health technology player focused on developing innovative devices and mobile health apps to improve the management of chronic and costly respiratory disorders.

The company’s new partner Grey Innovation is a commercialisation technology company based in Melbourne, which is working with universities and research institutes in Australia and Germany.

Respiri has partnered with Grey Innovation to ensure fast completion and low execution risk for the upgraded breath sensor.

Respiri’s flagship product AirSonea is an easy-to-use device that connects via Bluetooth with a sophisticated smartphone app to detect and measure wheeze.

The company has a first-mover advantage in providing broad access to its proprietary acoustic based clinical solutions for remote monitoring using over-the-counter connected devices.

Respiri products have been cleared for use by the U.S. FDA, the European Union, the Australian TGA and the commencement of an approval process for Asian markets has begun.



Register here to be notified of future RSH Company articles
View full RSH profile

Respiri Ltd Timeline

View All

Related Articles

© tech Capital 2017

Tech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed tech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Tech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Technology market.